Original news and analysis on international IP policy
The alleged intellectual property chapter of a secretive regional trade agreement between an association of ten Asian countries plus six others was released yesterday by a civil society group, which says richer countries in the region are pushing for stringent IP rules.
Countries develop intellectual property systems in different ways, and a recent conference at the World Intellectual Property Organization delved into some thoughts about, and examples of, how this is done.
KAMPALA -- The Republic of Uganda is in the process of signing the Swakopmund Protocol on the Protection of Traditional Knowledge and Expressions of Folklore, and the Arusha Protocol for the Protection of New Varieties of Plants.
World Intellectual Property Organization committee members last week agreed some new development projects and advanced discussions on the agency’s development dimension, including technical assistance, technology transfer and ties to the United Nations Sustainable Development Goals (SDGs). But negotiators could not complete a near-breakthrough on compromise measures to sharpen WIPO technical assistance through new guidelines, seminars, measurement tools, coordination, and tighter rules on selection of consultants.
The Russian government is considering approval of a package of controversial amendments to national legislation that would allow the use of inventions without the permission of patent holders.
Technical assistance provided by the World Intellectual Property Organization and the United Nations agency's technology transfer-related activities were discussed at length by WIPO member governments this week. At press time on the final day of a weeklong meeting, an updated proposal by Spain appeared to be bringing members nearer consensus on the way forward on WIPO technical assistance.
CAPE TOWN, South Africa - Health research collaborations between Africa and Europe do not match up with Africa’s own stated funding intentions, says a report published by a European Union-funded project.
Rejecting calls for a vote to be delayed until the European Commission proposes tougher whistle-blower protections, the European Parliament on 14 April approved by 503-131 new rules giving companies redress for theft or misuse of trade secrets. Debate on the trade secrets directive showed sharp divisions among lawmakers, heightened by the recent “Panama Papers” and other leaks, over whether the legislation will help businesses safeguard their innovative ideas or lead to increased corporate secrecy.
After waiting for over a decade, the World Trade Organization is finally close to achieving the first ever amendment to its rule-book, with only a handful of members still needing to formally accept new intellectual property provisions dealing with one aspect of access to medicines.
Two thirds of the membership (108 of the WTO’s present 162 members) have to ratify or “accept” the amendment (on exporting medicines made under compulsory licence) before it can take effect. The number of accepting members is finally approaching 108. This has exposed a discrepancy in the way the European Union’s membership is counted. And that in turn raises questions over when the 108 is actually reached.
Worse, the counting method the EU uses could even prevent some amendments ever taking effect.
New text-based government efforts to recommend to the World Intellectual Property Organization General Assembly which committees should report on their development activities have been unsuccessful so far this week. Separately, WIPO was asked by members to provide information on its involvement with the United Nations Secretary General’s High-Level Panel on Access to Medicines, and responded that it is in a delicate situation.
A study commissioned by the World Intellectual Property Organization to analyse which essential medicines on the 2013 World Health Organization Essential Medicines List were under patent found that over 90 percent of medicines on the list were off patent, and advocated more transparency in patent information. The study’s release set off an outcry among public health advocates who viewed the report as biased toward pharmaceutical companies.
A longstanding inquiry about alleged misconduct at the top of the World Intellectual Property Organization may be moving toward resolution one way or the other.